IDEX Biometrics ASA
IDBA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -84.1% | 8.4% | -30.2% | – |
| Cost of Goods Sold | $2 | $0 | $4 | $4 |
| Gross Profit | -$1 | $0 | -$3 | -$4 |
| % Margin | -2,423.3% | 39.5% | -912.9% | -731.2% |
| R&D Expenses | $1 | $1 | $1 | -$0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $3 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $3 | $0 | $0 |
| Operating Expenses | $3 | $6 | $2 | $2 |
| Operating Income | -$4 | -$6 | -$6 | -$6 |
| % Margin | -6,750% | -1,551.7% | -1,602.7% | -1,111.7% |
| Other Income/Exp. Net | $25 | -$1 | $1 | $0 |
| Pre-Tax Income | $21 | -$7 | -$5 | -$5 |
| Tax Expense | $6 | $0 | $0 | $0 |
| Net Income | $1 | -$7 | -$5 | -$5 |
| % Margin | 2,266.7% | -1,732.2% | -1,457% | -1,031% |
| EPS | 0.047 | -0.023 | -0.018 | -0.019 |
| % Growth | 306.2% | -23.9% | 2.9% | – |
| EPS Diluted | 0.046 | -0.023 | -0.018 | -0.019 |
| Weighted Avg Shares Out | 313 | 292 | 280 | 279 |
| Weighted Avg Shares Out Dil | 314 | 292 | 280 | 279 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | -$0 | $1 | $0 | $1 |
| EBITDA | $2 | -$5 | -$4 | -$5 |
| % Margin | 2,638.3% | -1,266.2% | -1,188.2% | -914.9% |